What the analysts haven't got and the Fin Review doesn't get is that a2 is a product disruptor- its a differentiator on health and taste grounds- its not the same as a1 milk- it tastes sweeter, it drinks smoother and you feel better in your gut.
Whats driving the sales is not the branding or the marketing its the quality of the product!
What the analysts haven't got and the Fin Review doesn't get is...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.74 |
Change
0.005(0.09%) |
Mkt cap ! $3.808B | |||
| Open | High | Low | Value | Volume |
| $5.73 | $5.75 | $5.68 | $2.469M | 431.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 8453 | $5.73 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.74 | 2187 | 8 |
View Market Depth
| Last trade - 13.19pm 29/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |
